Cheng Li

Cheng (Richard) Li has extensive work experience in the legal field. Cheng (Richard) is currently serving as the Chief Legal Officer at I-Mab Biopharma since March 2021. Prior to this role, they were an Of Counsel at Covington & Burling LLP from April 2020 to March 2021. Cheng (Richard) also worked as a Legal Director at 6 Dimensions Capital from May 2018 to March 2020. Before that, they were an Associate at Covington & Burling LLP from December 2013 to May 2018. Cheng (Richard) began their legal career as an Associate at Hogan Lovells from August 2008 to December 2013. Throughout their career, Cheng (Richard) Li has represented various multinational, start-up, and mid-size companies in life sciences transactions, mergers and acquisitions, PE/VC investments, joint ventures, and regulatory matters. Cheng (Richard) has worked with industry leaders and trade associations on complex regulatory and policy issues.

Cheng (Richard) Li obtained a Juris Doctor degree in Law from Columbia Law School. Additionally, they hold certifications such as cipp/A from IAPP - International Association of Privacy Professionals and CLP from Certified Licensing Professionals, Inc. Cheng (Richard) is also listed as having the PRC Legal Professional Qualification Certificate from PRC Ministry of Justice. However, information about the obtained month and year for the certifications and the institution for the New York State bar is not provided.